Each year, 50,000 new lung cancer cases are diagnosed in France, with non–small cell lung cancer (NSCLC ... Among the major advances presented at the congress were the findings from the ...

A 14-gene molecular assay may help identify early-stage non-squamous NSCLC patients who benefit from chemotherapy ...

A new study employing novel single-cell multimodal data revealed key insights into the tumor microenvironment predictive of NSCLC treatment response.

Cancer mRNA Vaccine Commercial Availability Expected By 2029 Says Kuick Research In New StudyDelhi, June 02, 2025 (GLOBE ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that it will present latest clinical ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

This breakthrough not only advances the treatment of non-small cell lung cancer but also marks a significant milestone in global oncology immunotherapy." "The interim analysis results from the ...

Christopher Danes, PhD, discusses a study exploring the differences in priorities for patients and their caregivers when undergoing treatment for non–small cell lung cancer.

The oral TKI sevabertinib has been granted priority review for use in patients harboring HER2 mutations in non-small cell ...

Basel: Roche has announced that the FDA has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic approved to aid in determining MET (also known as c-Met) protein expression ...

This breakthrough not only advances the treatment of non-small cell lung cancer but also marks a significant milestone in global oncology immunotherapy." ...